Company Filing History:
3 out of 28 
1 out of 4 Years Active: 2016-2019
Title: Michael Maynard-Smith: Innovator in Recombinant Antigens
Introduction
Michael Maynard-Smith is a notable inventor based in Salisbury, GB. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant antigens. With a total of three patents to his name, his work focuses on innovative solutions for the prevention and treatment of infections.
Latest Patents
Maynard-Smith's latest patents revolve around recombinant antigens that are based on fusion proteins. One of his inventions describes a fusion protein that consists of a first amino acid sequence with at least 80% sequence identity to specific regions of Toxin A and Toxin B sequences. This invention aims to provide antigens that can be used for the prevention, treatment, or suppression of Clostridium difficile infection (CDI). Another patent also focuses on recombinant antigens based on polypeptides with similar sequence identity, emphasizing the importance of specific amino acid residues for effective treatment methods.
Career Highlights
Throughout his career, Michael Maynard-Smith has worked with various organizations, including the Secretary of State for Health and Micropharm Limited. His experience in these roles has allowed him to develop and refine his innovative ideas in the field of biotechnology.
Collaborations
Maynard-Smith has collaborated with notable individuals such as Clifford Charles Shone and April Roberts. These partnerships have contributed to the advancement of his
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.